Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, May 4 2015

Full Issue

LifePoint Hospitals Profits Beat Expectations Due To Higher Admissions And Health Law

In other industry news, Myriad Genetics is fighting to sustain its business model nearly two years after the Supreme Court struck down gene patents. And Modern Healthcare's first quarterly poll of top health care leaders shows most support the trend toward value-based reimbursements.

The Wall Street Journal: LifePoint Hospitals Profit Rises On Higher Admissions

LifePoint Hospitals Inc. said on Friday that its profit rose 5% in the first quarter, as health-care reform continued to help drive higher admissions volumes. The rural hospital operator’s top and bottom lines surpassed analysts’ expectations, but the company’s shares fell about 6% in midday trading as investors focused on a deceleration in same-hospital admissions and took profits after shares rose more than 30% over the past 12 months. (Beilfuss, 5/1)

The Wall Street Journal: Myriad Genetics Fights Off Threats From Rivals

Myriad Genetics Inc. used a patent-protected monopoly to become one of the most successful and controversial DNA testing companies in the world. Now, nearly two years after the Supreme Court struck down its gene patents, Myriad is fighting to sustain its business model amid growing threats from rivals. (Walker, 5/3)

Modern Healthcare: CEO Power Panel Poll Finds Broad Support For Value-Based Pay

More than three-quarters of a representative sample of the nation's top healthcare leadership back the ongoing shift toward value-based payment systems, which reward providers for what they achieve rather than what they do. Yet only 20% are willing to do away completely with the industry's still dominant fee-for-service reimbursement model, according to the first quarterly poll of Modern Healthcare's CEO Power Panel. (Conn and Sandler, 5/2)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF